# Insulin Schemes for Type 2 Diabetes Control

> **NCT03350984** · PHASE4 · COMPLETED · sponsor: **Universidad de Guanajuato** · enrollment: 75 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** NPH insulin
- **DRUG:** Glargine and Lispro insulin

## Key facts

- **NCT ID:** NCT03350984
- **Lead sponsor:** Universidad de Guanajuato
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-02
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350984, "Insulin Schemes for Type 2 Diabetes Control". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03350984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*